Kalaris Therapeutics (KLRS) Return on Assets [ROA] (2020 - 2026)
Kalaris Therapeutics (KLRS) recorded Return on Assets [ROA] of -45.63% in Q2 2026, up 24.07 percentage points from -69.70% a year earlier but down 4.49 percentage points from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Return on Assets [ROA] (2020 - 2026) Analysis & Trends
For FY2025, Kalaris Therapeutics reported Return on Assets [ROA] of -74.43%, down 14.75 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of -47.07 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -59.68% in FY2024 (+21.72 pp), -81.40% in FY2023 (-21.54 pp), -59.86% in FY2022 (-7.55 pp) and -52.31% in FY2021 (-24.96 pp).
- Quarterly Return on Assets [ROA] has ranged from -108.64% in Q1 2025 to -41.14% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Assets [ROA] has increased for five consecutive quarters, with an average year-over-year change of +16.97 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 67.50 percentage points in Q1 2026, against a drop of 54.27 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -41.14% (Q1 2026), -46.91% (Q4 2025) and -50.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Kalaris Therapeutics | 44.52 Mn | -38.38 Mn | - | -46.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -46.11% |
| Jun 30, 2026 | -42.36% |
| Mar 31, 2026 | -38.13% |
| Dec 31, 2025 | -42.81% |
| Sep 30, 2025 | -63.74% |
| Jun 30, 2025 | -83.35% |
| Mar 31, 2025 | -139.83% |
| Dec 31, 2024 | -150.07% |
| Sep 30, 2024 | -105.79% |
| Jun 30, 2024 | -101.96% |
| Mar 31, 2024 | -107.11% |
| Dec 31, 2023 | -86.54% |
| Sep 30, 2023 | -63.46% |
| Jun 30, 2023 | -63.20% |
| Mar 31, 2023 | -63.70% |
| Dec 31, 2022 | -59.23% |
| Sep 30, 2022 | -76.54% |
| Jun 30, 2022 | -89.25% |
| Mar 31, 2022 | -71.57% |
| Dec 31, 2021 | -57.04% |
API Access
Kalaris Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();